p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy - Concepedia

Concepedia

Publication | Open Access

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy

DOI Full Paper Access

50

Citations

39

References

2019

Year

Hyeon Jeong Oh, Jeong Mo Bae, Xianyu Wen, Seorin Jung, Young-Hoon Kim, Kyung Ju Kim, Nam‐Yun Cho, Jung Ho Kim, Sae‐Won Han, Tae‐You Kim,

British Journal of Cancer

Abstract

p53-mild expression status was found to be an independent prognostic marker in adjuvant FOLFOX-treated patients with stage III and high-risk stage II CRC.

References

	Year	Citations

Page 1